The xanthine oxidase inhibitory activity and hypouricemia effect of the propolis in rats

Yakugaku Zasshi

Volumn 125, Issue 3, 2005, Pages 315-321

  Yoshizumi, Kazuma ^a   Nishioka, Nobuo ^b   Tsuji, Tomoko ^a  

^a Central Research Development Laboratory Fancl Corporation   (Japan)

^b Morikawa Kenkodo Co Ltd   (Japan)

Author keywords

Gout and hyperuricemia; Oxonic acid; Propolis; Uric acid; Xanthine oxidase inhibitor

Indexed keywords

ARTEPILLIN C; CAFFEIC ACID PHENETHYL ESTER; CHRYSIN; ENZYME INHIBITOR; GALANGIN; OXONIC ACID; PARA COUMARIC ACID; PROBENECID; PROPOLIS; UNCLASSIFIED DRUG; URATE OXIDASE; XANTHINE OXIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG STRUCTURE; ENZYME INHIBITION; EVALUATION; GEOGRAPHIC ORIGIN; GOUT; HYPERURICEMIA; NONHUMAN; QUANTITATIVE ASSAY; RAT; URIC ACID BLOOD LEVEL;

ANIMALS; ANTI-INFECTIVE AGENTS; BRAZIL; CAFFEIC ACIDS; CHINA; COUMARIC ACIDS; DISEASE MODELS, ANIMAL; FLAVONOIDS; GOUT; HYPERURICEMIA; MALE; OXONIC ACID; PHENYLETHYL ALCOHOL; PHENYLPROPIONATES; PROPOLIS; RATS; RATS, SPRAGUE-DAWLEY; URIC ACID; XANTHINE OXIDASE;

EID: 18244363611     PISSN: 00316903     EISSN: None     Source Type: Journal    
DOI: 10.1248/yakushi.125.315     Document Type: Article

References (24)

1. Terai C., Naika, 85, 375-377 (2000).
2. Fujimori S., Rinshou Eiyou, 97, 709-715 (2000).
3. Hikita M., Gout Nucleic Acid Metab., 24, 139-151 (2000).
4. Nakajima H., Hyperuricemia Gout, 9, 21-26 (2001).
5. Yamamoto T., Hyperuricemia Gout, 9, 16-20 (2001).
6. Matsuno T., Z. Naturforsch., 50c, 93-97 (1995).
7. Wang L., Mineshita S., Ga I., Shigematsu T., Matsuno T., Jpn. J. Pharmacol. Ther., 24, 223-224 (1993).
8. Hayashi K., Komura S., Ohishi N., Yagi K., Chem. Pharm. Bull., 47, 1521-1524 (1999).
9. Tatefuji T., Izumi N., Ohta T., Arai S., Ikeda M., Kurimoto M., Biol. Pharm. Bull., 19, 966-970 (1996).
10. Amoros M., Lurton E., Bousite J., Girre L., Sauvager F., Cormier M., J. Nat. Prod., 57, 644-647 (1994).
11. Sugimoto Y., Tarumi T., Kaneko Y., Isayama S., Kawai N., Sugimoto H., Yamada H., Kamei C., Biol. Pharm. Bull., 22, 1237-1239 (1999).
12. Tazawa S., Warashina T., Noro T., Nat. Med., 54, 306-313 (2000).
13. Kumazawa S., Nakayama T., Honeybeen Sci., 22, 1-8 (2001).
14. Chang W. S., Lee Y. J., Lu F. S., Chiang H. C., Anticancer Res., 13, 2165-2170 (1993).
15. Nagao A., Seki M., Kobayashi H., Biosci. Biotech. Biochem., 63, 1787-1790 (1999).
16. Alberto B., Marina V., Lucia C., Pharmaco. Res. Commun., 17, 831-839 (1985).
17. Chang W. S., Chiang H. C., Anticancer Res., 15, 1969-1974 (1995).
18. Chan W. S., Wen P. C., Chiang H. C., Anticancer Res., 15, 703-708 (1995).
19. Osada Y., Tsuchimoto M., Fukushima H., Takahashi K., Kondo S., Hasegawa M., Komoriya K., Eur. J. Pharmacol., 241, 183-188 (1993).
20. Yonetani Y., Ishii M., Iwaki K., Jpn. J. Pharmacol., 30, 829-840 (1980).
21. Unno T., Sakane I., Kakuda T., Nippon Shokuhin Kagaku Kogaku Kaishi, 47, 740-743 (2000).
22. Koguchi T., Nakajima H., Wada M., Yamamoto Y., Innami S., Maekawa A., Tadokoro T., J. Nutr. Sci. Vitaminol., 48, 184-193 (2002).
23. Inoki A., Yamaguchi Y., J. Nutr. Food, 4, 103-112 (2001).
24. Stavric B., Nera E. A., Clin. Toxicol., 13, 47-74 (1978).